ID26809A - Senyawa-senyawa turunan sianoiminokuinoksalin - Google Patents
Senyawa-senyawa turunan sianoiminokuinoksalinInfo
- Publication number
- ID26809A ID26809A IDW20002390A ID20002390A ID26809A ID 26809 A ID26809 A ID 26809A ID W20002390 A IDW20002390 A ID W20002390A ID 20002390 A ID20002390 A ID 20002390A ID 26809 A ID26809 A ID 26809A
- Authority
- ID
- Indonesia
- Prior art keywords
- sianoiminokuinoksalin
- compounds
- compound
- ncn
- independently
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 206010001497 Agitation Diseases 0.000 abstract 1
- 102000018899 Glutamate Receptors Human genes 0.000 abstract 1
- 108010027915 Glutamate Receptors Proteins 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- MORUUIHTOGRZPK-UHFFFAOYSA-N quinoxalin-2-ylcyanamide Chemical class C1=CC=C2NC(=NC#N)C=NC2=C1 MORUUIHTOGRZPK-UHFFFAOYSA-N 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
- C07D241/52—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15101798 | 1998-06-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID26809A true ID26809A (id) | 2001-02-08 |
Family
ID=15509486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW20002390A ID26809A (id) | 1998-06-01 | 1999-05-28 | Senyawa-senyawa turunan sianoiminokuinoksalin |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6525054B1 (de) |
| EP (1) | EP1097927B1 (de) |
| JP (1) | JP3231338B2 (de) |
| KR (1) | KR20010043981A (de) |
| CN (1) | CN1304404A (de) |
| AT (1) | ATE333447T1 (de) |
| AU (1) | AU744274B2 (de) |
| BR (1) | BR9910859A (de) |
| CA (1) | CA2333515A1 (de) |
| DE (1) | DE69932441T2 (de) |
| HU (1) | HUP0102854A3 (de) |
| ID (1) | ID26809A (de) |
| IL (1) | IL139783A0 (de) |
| NO (1) | NO20006065L (de) |
| NZ (1) | NZ508280A (de) |
| PL (1) | PL344406A1 (de) |
| RU (1) | RU2217426C2 (de) |
| TR (1) | TR200003572T2 (de) |
| WO (1) | WO1999062887A1 (de) |
| ZA (1) | ZA200006838B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100581344B1 (ko) * | 2003-05-02 | 2006-05-23 | 주식회사디엔에이링크 | 텔로머라제 활성 억제용 조성물 |
| EP2241557A1 (de) | 2009-04-02 | 2010-10-20 | Æterna Zentaris GmbH | Chinoxalin-Derivate und deren Anwendung zur Behandlung gutartiger und bösartiger Tumorerkrankungen |
| CN104177595A (zh) * | 2013-05-28 | 2014-12-03 | 海洋王照明科技股份有限公司 | 含喹喔啉基的聚合物及其制备方法和有机太阳能电池器件 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE194985T1 (de) * | 1990-11-06 | 2000-08-15 | Yamanouchi Pharma Co Ltd | Kondensiertes pyrazinderivat |
| US6369057B1 (en) | 1991-04-15 | 2002-04-09 | Aventis Pharma Deutschland Gmbh | Quinoxalines, processes for their preparation and their use |
| AU688459B2 (en) | 1994-04-08 | 1998-03-12 | Shionogi & Co., Ltd. | Oxopyridinylquinoxaline derivative |
| DE69524246T2 (de) * | 1994-09-27 | 2002-06-27 | Yamanouchi Pharmaceutical Co., Ltd. | 1,2,3,4-Tetrahydroquinoxalindion Derivate und ihre Verwendung als Glutamat Rezeptor Antagonisten |
| HUT76302A (en) * | 1995-11-30 | 1997-07-28 | Chinoin Gyogyszer Es Vegyeszet | Quinoxaline derivatives, pharmaceutical compositions containing them and process for producing them |
| AUPN842196A0 (en) | 1996-03-05 | 1996-03-28 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
| AU2213197A (en) | 1996-03-05 | 1997-09-22 | Medinox, Inc. | Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor |
-
1999
- 1999-05-28 PL PL99344406A patent/PL344406A1/xx not_active Application Discontinuation
- 1999-05-28 IL IL13978399A patent/IL139783A0/xx unknown
- 1999-05-28 KR KR1020007013611A patent/KR20010043981A/ko not_active Ceased
- 1999-05-28 WO PCT/JP1999/002822 patent/WO1999062887A1/ja not_active Ceased
- 1999-05-28 AU AU39553/99A patent/AU744274B2/en not_active Ceased
- 1999-05-28 BR BR9910859-3A patent/BR9910859A/pt not_active IP Right Cessation
- 1999-05-28 DE DE69932441T patent/DE69932441T2/de not_active Expired - Fee Related
- 1999-05-28 RU RU2001101155/04A patent/RU2217426C2/ru not_active IP Right Cessation
- 1999-05-28 ID IDW20002390A patent/ID26809A/id unknown
- 1999-05-28 CN CN99806926A patent/CN1304404A/zh active Pending
- 1999-05-28 US US09/701,383 patent/US6525054B1/en not_active Expired - Fee Related
- 1999-05-28 HU HU0102854A patent/HUP0102854A3/hu unknown
- 1999-05-28 CA CA002333515A patent/CA2333515A1/en not_active Abandoned
- 1999-05-28 AT AT99922540T patent/ATE333447T1/de not_active IP Right Cessation
- 1999-05-28 JP JP55654899A patent/JP3231338B2/ja not_active Expired - Fee Related
- 1999-05-28 TR TR2000/03572T patent/TR200003572T2/xx unknown
- 1999-05-28 NZ NZ508280A patent/NZ508280A/xx unknown
- 1999-05-28 EP EP99922540A patent/EP1097927B1/de not_active Expired - Lifetime
-
2000
- 2000-11-22 ZA ZA200006838A patent/ZA200006838B/en unknown
- 2000-11-29 NO NO20006065A patent/NO20006065L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2217426C2 (ru) | 2003-11-27 |
| IL139783A0 (en) | 2002-02-10 |
| AU744274B2 (en) | 2002-02-21 |
| CN1304404A (zh) | 2001-07-18 |
| EP1097927A1 (de) | 2001-05-09 |
| HUP0102854A3 (en) | 2002-07-29 |
| US6525054B1 (en) | 2003-02-25 |
| AU3955399A (en) | 1999-12-20 |
| ATE333447T1 (de) | 2006-08-15 |
| TR200003572T2 (tr) | 2001-06-21 |
| NO20006065D0 (no) | 2000-11-29 |
| NO20006065L (no) | 2001-01-31 |
| PL344406A1 (en) | 2001-11-05 |
| WO1999062887A1 (fr) | 1999-12-09 |
| EP1097927B1 (de) | 2006-07-19 |
| DE69932441T2 (de) | 2007-03-15 |
| CA2333515A1 (en) | 1999-12-09 |
| BR9910859A (pt) | 2001-03-13 |
| NZ508280A (en) | 2002-09-27 |
| HUP0102854A2 (hu) | 2002-03-28 |
| KR20010043981A (ko) | 2001-05-25 |
| EP1097927A4 (de) | 2002-08-07 |
| JP3231338B2 (ja) | 2001-11-19 |
| DE69932441D1 (de) | 2006-08-31 |
| ZA200006838B (en) | 2001-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69418704D1 (de) | Anthranilsäure derivate | |
| BR9910621A (pt) | Novos compostos de imidazol 2-alquil substituìdos | |
| DE69519469D1 (de) | Chinazolin-derivate | |
| PT846686E (pt) | Derivados de 1-fenil-pirazole e suas utilizacoes como agentes parasiticidas | |
| PT870768E (pt) | Derivados azaindole-etilamina como agentes de ligacao nicotinicos aos receptores de acetilcolina | |
| DK1043310T3 (da) | Biphenylamidinderivater | |
| EE200000059A (et) | Tetrahüdro-gamma-karboliinid | |
| AR003137A1 (es) | Una composicion farmaceutica para tratar la leucemia | |
| ATE246686T1 (de) | Pyrrolocarbazolderivate | |
| NO20006065L (no) | Cyanoiminokinoksalinderivater | |
| DE69621506D1 (de) | Substituierte Aminochinazolinon (thion) Derivate und deren Sälze, deren Zwischenprodukten und Pestkontrollemittel und deren Verwendungsmittel | |
| EA200401099A1 (ru) | Производные гетероциклического амида | |
| BR0002514A (pt) | Derivados de 4-arilpiperidina para o tratamento de prurido | |
| ATE222583T1 (de) | Derivate substituierter amidinonaphthylester | |
| FI822706L (fi) | Foerfarande foer framstaellning av farmakologiskt aktiva heteroaryloxipropanolaminer | |
| ES2168119T3 (es) | Derivados de quinoxalina para el tratamiento de tinnitus. | |
| ES2141134T3 (es) | Derivados de carbamoil pirrolidona para el tratamiento de la depresion y de los trastornos cerebrovasculares. | |
| ATE208761T1 (de) | Quinolin-derivate und diese enthaltende pharmazeutische zusammensetzungen |